Physician profile
Ryan Stark Suplee
NPI 1013232289
$63,861.58
in general payments reported to CMS, 2019-2025
25 companies · $9,241 in 2025
The $9,241 reported for 2025 was more than what 90% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,483 · 2020: $738 · 2021: $14K · 2022: $29K · 2023: $1,323 · 2024: $6,878 · 2025: $9,241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Food and Beverage: $4,942.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,500.00 |
| Food and Beverage | $4,942.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $53,278.45 | 2021-2025 | Solus Alif, Other - Miscellaneous |
| Silk Road Medical, INC. | $2,396.90 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| W. L. Gore & Associates, INC. | $1,639.60 | 2019-2025 | Gore Tag Conformable Thoracic Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Excluder Iliac Branch Endoprosthesis |
| Penumbra, INC. | $1,174.70 | 2019-2025 | Indigo System, Ruby Coil, Penumbra System |
| Boston Scientific Corporation | $1,134.36 | 2019-2025 | Eluvia, Varithena Administration Pack, Enroute Transcarotid Neuroprotection System |
| Medtronic Vascular, INC. | $817.96 | 2019-2020 | |
| Nuvasive, INC. | $691.60 | 2019 | |
| Philips North America LLC | $611.29 | 2022-2025 | (Az7) Lasers, Labosys, Other Rental |
| Cvrx, INC. | $549.30 | 2021-2023 | Barostim Neo System |
| Medtronic, INC. | $506.59 | 2021-2024 | Endurant Iis, In.Pact Admiral |
| Medtronic USA, INC. | $260.36 | 2019-2020 | |
| Abbott Laboratories | $170.72 | 2020-2025 | Esprit |
| Inari Medical, INC. | $105.13 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Smith+Nephew, INC. | $97.53 | 2024-2025 | Collagenase Santyl, Pico, Renasys Touch |
| Cardiovascular Systems INC. | $82.89 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $77.82 | 2025 | Flexitouch Plus, Nimbl |
| Angiodynamics, INC. | $41.86 | 2025 | Auryon Laser System 100-120 Vac |
| Inspiremd LTD | $41.14 | 2025 | Cguard Prime Carotid Stent System |
| Stryker Corporation | $39.32 | 2025 | Flowtriever, Artix Mt |
| Ethicon US, LLC | $31.82 | 2023 | Echelon; Endopath, Vistaseal, Enseal |
| Cashflow Solutions, LLC | $28.89 | 2023-2025 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Mimedx Group, INC. | $23.17 | 2024 | |
| Aroa Biosurgery Incorporated | $23.04 | 2025 | |
| Polymedics Innovations INC. | $18.79 | 2024 | |
| Lemaitre Vascular, INC. | $18.35 | 2025 | Artegraft Vascular Graft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Suplee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.